Boston Scientific launches next generation asthma therapy Ruby Khatun Khatun15 Jun 2017 9:45 AM ISTMumbai: Boston Scientific India announced that it has launched the next generation asthma therapy in the country to address the needs of patients with...
Board of Kovai Medical Center and Hospital recommends final dividend Ruby Khatun Khatun15 Jun 2017 9:45 AM ISTThe board Of Kovai Medical Center and Hospital have recommended the final dividend of Rs 2.5 per equity Share.Kovai Medical Center and Hospital Ltd...
Zydus Cadila gets USFDA nod for ezetimibe tablets Ruby Khatun Khatun14 Jun 2017 11:52 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received approval from the US health regulator to market ezetimibe tablets used to treat high...
Aster DM Healthcare eyes Saudi market despite past payment delays Ruby Khatun Khatun14 Jun 2017 11:45 AM ISTDUBAI: Dubai-based Aster DM Healthcare is looking at acquisition opportunities in Saudi Arabia, its managing director told Reuters in an...
Johnson & Johnson diabetes drug, Invokana shows heart benefit in large safety study Ruby Khatun Khatun14 Jun 2017 11:44 AM ISTJohnson & Johnson's type 2 diabetes drug Invokana significantly reduced the risk of serious heart problems in patients with established heart...
Suven Life Sciences gets patents for anti-neuro degeneration molecule Ruby Khatun Khatun14 Jun 2017 11:43 AM ISTNew Delhi: Drug firm Suven Life Sciences has received one product patent each from Australia and the US for its molecule to be used in the treatment...
Sun Pharma receives USFDA nod for anti-cholesterol drug Ruby Khatun Khatun14 Jun 2017 11:43 AM ISTNew Delhi: Drug major Sun Pharmaceutical Industries' wholly-owned subsidiary has received nod from the US health regulator for its generic version of...
Strides Shasun gets USFDA nod for pain relieving drug Ruby Khatun Khatun13 Jun 2017 12:17 PM ISTNew Delhi: Drug firm Strides Shasun has received the US health regulator's nod for Amantadine Hydrochloride tablets, used in the treatment of...
Bayer, Johnson & Johnson win second US trial over Xarelto bleeding risks Ruby Khatun Khatun13 Jun 2017 12:13 PM ISTA federal jury has cleared Bayer AG and Johnson & Johnson of liability in the second trial to stem from thousands of lawsuits blaming injuries on...
After Stents and Catherter, FDA moves Scanner to Intraocular Lenses Ruby Khatun Khatun13 Jun 2017 9:17 AM ISTNew Delhi: After making revelations of unjust profit margins on cardiac catheters last week, the Mahashtra FDA was recently seen making more...
FDA rejects Coherus' biosimilar for Amgen's Neulasta Ruby Khatun Khatun13 Jun 2017 9:12 AM ISTn" style="transform: translate3d(0px, 0px, 0px);"Coherus BioSciences Inc said on Monday the U.S. Food and Drug Administration (FDA) denied the...
Zydus Nesher Pharmaceuticals gets FDA nod for antifungal drug Ruby Khatun Khatun12 Jun 2017 11:30 AM ISTNew Delhi: Zydus Group firm Cadila Healthcare said its subsidiary Nesher Pharmaceuticals has received nod from the USFDA to market Nystatin topical...
